References
- Bellm J. Needle-exchange programmes are not the answer [letter; comment]. Lancet 1999; 353: 1657–1661, [CSA]
- Bluthenthal R. N., Kral A. H., Gee L., et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 2000; 14: 605–611, [CSA], [CROSSREF]
- Corneil T. A., Kuyper L. M., Shovellor J., et al. Unstable housing, associated risk behavior, and increased risk for HIV infection among injection drug users. Health and Place 2006; 12: 79–85, [CSA], [CROSSREF]
- Des Jarlais D. C., Marmor M., Paone D., et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348: 987–991, [CSA], [CROSSREF]
- Doherty M. C., Junge B., Rathouz P., et al. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. American Journal of Public Health 2000; 90: 936–939, [CSA]
- Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797–1800, [CSA], [CROSSREF]
- Miller C. L., Kerr T., Frankish J. C., et al. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Substance Use & Misuse 2006; 41: 199–210, [CSA], [CROSSREF]
- Miller C. L., Spittal P. M., LaLiberte N., et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndromes 2002; 30: 335–341, [CSA]
- Schechter M. T., Strathdee S. A., Cornelisse P. G., et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS 1999; 13: F45–F51, [CSA], [CROSSREF]
- Small W., Kain S., Laliberte N., et al. Incarceration, addiction, and harm reduction: inmates' experience injecting drugs in prison. Substance Use & Misuse 2003; 40: 831–843, [CSA]
- Spittal P., Small W., Laliberte N., et al. How otherwise well meaning exchange agents can contribute to limited sterile syringe availability in Vancouver, Canada. International Journal of Drug Policy 2003; 15: 36–45, [CSA], [CROSSREF]
- Strathdee S. A., Patrick D. M., Currie S. L., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11: F59–F65, [CSA], [CROSSREF]
- Tyndall M. W., Bruneau J., Brogly S., et al. Satellite needle distribution among injection drug users: policy and practice in two canadian cities. Journal of Acquired Immune Deficiency Syndromes 2002; 31: 98–105, [CSA]
- Tyndall M. W., Currie S., Spittal P., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003; 17: 887–893, [PUBMED], [CSA], [CROSSREF]
- Wood E., Li K., Montaner J. S., et al. Incarceration is associated with syringe sharing among injection drug users. Public Health Reports 2004a; 120: 150–156, [CSA]
- Wood E., Spittal P. M., Li K., et al. Inability to access addiction treatment and risk of HIV-infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes 2004b; 36: 750–756, [CSA]
- Wood E., Tyndall M. W., Spittal P., et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy 2002a; 13: 95–102, [CSA], [CROSSREF]
- Wood E., Tyndall M. W., Spittal P. M., et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002b; 16: 941–943, [CSA], [CROSSREF]
- Wood E., Tyndall M. W., Spittal P. M., et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. Canadian Medical Association Journal 2001; 165: 405–410, [PUBMED], [CSA]